Search results
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Integrated Advisors Network LLC
ETF DAILY NEWS· 14 hours agoIntegrated Advisors Network LLC cut its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.2% during the fourth quarter, according ...
Kapitalo Investimentos Ltda Purchases 130 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 2 days agoKapitalo Investimentos Ltda increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 118.2% in the fourth quarter, according ...
Regeneron Pharmaceuticals (NASDAQ:REGN) Sets New 52-Week High Following Analyst Upgrade
ETF DAILY NEWS· 3 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) shares reached a new 52-week high during mid-day trading on Monday after JPMorgan Chase ...
Insider Selling: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) CEO Sells 9,064 Shares of Stock
ETF DAILY NEWS· 6 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) CEO Leonard S. Schleifer sold 9,064 shares of the company’s stock in a transaction on Tuesday ...
Regeneron director Brown sells shares worth over $1.5 million By Investing.com
Investing.com· 3 days agoRegeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:REGN) Director Michael S. Brown has completed...
Investors in Regeneron Pharmaceuticals (NASDAQ:REGN) have seen stellar returns of 220% over the past...
Simply Wall St. via Yahoo Finance· 6 days agoBut on a lighter note, a good company can see its share price rise well over 100%. Long term ...
Regeneron (REGN) Outperforms Industry YTD: What Lies Ahead?
Zacks via Yahoo Finance· 2 days agoBiotech giant Regeneron Pharmaceuticals REGN is one of the few top biotech companies that has...
Why Wall Street Is Chasing Ozempic Wannabes
The Wall Street Journal· 35 minutes agoCompanies including Roche, AstraZeneca Amgen Pfizer, and Regeneron Pharmaceuticals are all developing drugs of their own. Even Merck told attendees at a...
Regeneron holds Buy rating and price target from TD Cowen By Investing.com
Investing.com· 6 days agoOn Friday, TD Cowen maintained a Buy rating on shares of Regeneron (NASDAQ:REGN) Pharmaceuticals...
...Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN - ...
Benzinga· 5 days agoNEW YORK, June 15, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ:REGN). Such investors are
